Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib and Paclitaxel in Melanoma
NCT01666418Phase 2Completed
- Sponsor
- University of Zurich
- Start
- Aug 2012
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in melanoma, sponsored by University of Zurich. Started Aug 2012; status: completed.
02
Drugs
pazopanib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01666418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01666418.